Form 8K PALATIN
TECHNOLOGIES For: 18 May
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Palatin Technologies Inc (PTN)
Palatin Technologies Inc stock price live, this page displays NASDAQ PTN stock exchange data. View the PTN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Palatin Technologies Inc real time stock price chart below.
What Is the Palatin Technologies Inc Stock Price Today?
The Palatin Technologies Inc stock price today is 10.49.
What Is the Stock Symbol for Palatin Technologies Inc?
The stock symbol for Palatin Technologies Inc is "PTN."
What Stock Exchange Does Palatin Technologies Inc Trade On?
Palatin Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Palatin Technologies Inc a Good Stock to Buy?
Determining whether Palatin Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PTN quote. (ISIN: US6960776010)
What Is the Palatin Technologies Inc Stock Price Today?
The Palatin Technologies Inc stock price today is 10.49.
What Is the Stock Symbol for Palatin Technologies Inc?
The stock symbol for Palatin Technologies Inc is "PTN."
What Stock Exchange Does Palatin Technologies Inc Trade On?
Palatin Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Palatin Technologies Inc a Good Stock to Buy?
Determining whether Palatin Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PTN quote. (ISIN: US6960776010)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.55
10.49
52 wk Range
5.61
31.00
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.5510.49
52 wk Range
5.6131.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PTN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K PALATIN TECHNOLOGIES For: 18 May
- Investing.com
Form 13G PALATIN TECHNOLOGIES INC For: 15 May- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Palatin Technologies Inc Earnings Call Summary for Q3/2026
- Q3 FY2026 revenue surged to $3.9M from $0 YoY, driven by Altanispac sub-licensing agreement for PL9643 program
- Net loss narrowed significantly to $1.4M ($0.37/share) from $4.8M ($9.13/share) YoY; cash burn reduced 18.5%
- Operating expenses rose to $5.5M from $4.4M due to increased compensation and professional fees
- Stock jumped 4.06% premarket; analysts set price targets at $50-$60 vs current $17.51, reflecting partnership optimism
- FY2026 revenue guidance set at $11.51M; negative EPS projections continue with -$2.65 expected for Q4 FY2026
Last Updated: 2026-05-13, 11:46 a/m
Read Full TranscriptEarnings
Latest Release
May 13, 2026
EPS / Forecast
-0.37 / -1.26
Revenue / Forecast
3.92M / --
Compare PTN to Peers and Sector
Metrics to compare | PTN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPTNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −1.7x | −0.4x | |
PEG Ratio | −0.03 | −0.04 | 0.00 | |
Price/Book | 1.8x | 3.2x | 2.6x | |
Price / LTM Sales | 1.5x | 6.8x | 3.1x | |
Upside (Analyst Target) | - | 79.3% | 47.0% | |
Fair Value Upside | Unlock | 6.2% | 5.6% | Unlock |
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Palatin Tech (PTN) Stock Price Today?
The Palatin Tech stock price today is 10.49 USD.
What Stock Exchange Does Palatin Tech Trade On?
Palatin Tech is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Palatin Tech?
The stock symbol for Palatin Tech is "PTN."
What Is the Palatin Tech Market Cap?
As of today, Palatin Tech market cap is 19.55M USD.
What Is Palatin Tech's Earnings Per Share (TTM)?
The Palatin Tech EPS (TTM) is -3.04.
When Is the Next Palatin Tech Earnings Date?
Palatin Tech will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is PTN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Palatin Tech Stock Split?
Palatin Tech has split 1 times.
How Many Employees Does Palatin Tech Have?
Palatin Tech has 29 employees.
What is the current trading status of Palatin Tech (PTN)?
As of Aug 28, 2026, Palatin Tech (PTN) is trading at a price of 10.49 USD, with a previous close of 10.49 USD. The stock has fluctuated within a day range of 9.55 USD to 10.49 USD, while its 52-week range spans from 5.61 USD to 31.00 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.